Ministers will end Palantir's NHS data contract, but not until 2029
Why it hits youThis is software that handles NHS patient records, including yours if you're treated at a hospital that uses it. Palantir was co-founded by Peter Thiel, an early supporter of Donald Trump, and works for the US immigration agency ICE and Israel's military, which is why tens of thousands of people have objected to it holding their data. For now, nothing changes at your hospital.
The US tech firm Palantir runs the software that links up data across hospitals in England. Ministers could have ended its £330m deal next spring. Instead they're letting it run two more years while they find new suppliers, ideally British ones. Campaigners and many MPs say that's two years too long. Palantir calls it good news for patients.
The Facts
What everyone agrees on
Before anyone spins it. Every one of these is checkable.
-
The Department of Health and Social Care is extending Palantir's contract for the NHS Federated Data Platform (FDP) by two years, instead of using a break clause that would have let it end the deal next spring. The Guardian ↗
-
After a statement to MPs by health minister James Frith, the Palantir contract will now run until March 2029. The Guardian (politics live) ↗
-
The NHS will start talking to patients, partners and companies in January. Formal procurement begins in the second half of 2027 and is expected to take around 18 months. The Guardian (politics live) ↗
-
A group led by Palantir won a £330m deal in 2023 to build the platform. The contract could have run until 2031. The Independent ↗
-
The platform is built on Palantir's Foundry software and is used for tasks like managing surgery waiting lists and hospital discharges. NHS England says Palantir cannot sell NHS data or use it to train AI. NHS England ↗
-
The national data opt-out does not currently apply to the FDP. Patients can't opt out, but hospital trusts can choose not to use it. The Register ↗
-
More than 44,000 people have filed legal objections to their data being handled by the platform. The Guardian ↗
-
NHS England deleted a claim that 137 trusts were benefiting from the platform after 29 said they weren't using all or most of it. The Guardian ↗
Every Side · 1 of 3
MPs and campaigners
Good that it's ending, but why wait two years?
Labour MP Chi Onwurah, who chairs the Commons science committee, said: “If a break clause cannot be exercised because of continuity of care, it is not a break clause, it is a lock-in.” Lib Dem MP Martin Wrigley said ministers had “kicked the can down the road to March 2029”, leaving Palantir “holding the keys to our health data for years to come”. Amnesty International called the decision “a victory for healthcare workers, patients and campaigners who refused to give up”, but added: “The next two years must be about extracting Palantir from our NHS, not allowing it to become more deeply embedded.” Labour MP John McDonnell wants the next contract to demand a “humanitarian track record”, so Palantir can be told “no need to apply”.
- Dame Chi Onwurah, chair of the Commons science and technology committee
- Martin Wrigley, Liberal Democrat MP
- Tom Guha, Amnesty International UK
- John McDonnell, Labour MP
Side labels are our editorial calls for now. How we'll rate lean
Every Side · 2 of 3
What it means for you
Nothing changes at your hospital yet, and you can't simply opt out
The Federated Data Platform helps hospitals manage things like waiting lists, operating theatre schedules and getting patients discharged. NHS England says your identifiable data stays inside your own hospital trust's part of the system, and that Palantir can't sell NHS data or use it to train AI. The usual NHS opt-out doesn't cover it. In June, health minister Preet Kaur Gill told MPs: “The National Data Opt-Out does not currently apply to products used in the NHS FDP.” More than 44,000 people have instead used data protection law to formally object to the platform handling their data. NHS England said it would “respond to the objection requests in line with data protection law”. The NHS will start talking to patients and companies about the replacement from January.
- Preet Kaur Gill, health minister (June)
- NHS England
- 38 Degrees
Side labels are our editorial calls for now. How we'll rate lean
Every Side · 3 of 3
Palantir and its defenders
The platform is working, so keep it going
Tom Watson, Palantir UK's senior vice-president, said: “This is good news for patients and for the NHS.” He said the company is proud of its work “to help deliver more operations, speed up discharge and reduce the time patients need to wait to find out if they have cancer”. Palantir says trusts using its software have recorded 117,000 extra operations. Health minister James Frith said the decision was “not about the politics of executives of suppliers, nor is it about the territories or customers that one company or one supplier makes”. For the Conservatives, Damian Hinds warned against picking suppliers on “Labour MPs’ tastes or distastes”, saying: “It should be about delivering the right spec at the right price for optimal patient care.”
- Tom Watson, senior vice president, Palantir UK
- James Frith, health minister
- Damian Hinds, shadow health secretary
Side labels are our editorial calls for now. How we'll rate lean
The Blindspot · what the headlines skip
Critics skip how hard a quick switch would be
In a letter to MPs, Frith warned it was “unlikely that a new contract could be in place by March” because of how long normal government procurement takes. In June, minister Preet Kaur Gill said moving to a new supplier “would take planning, time, and resources”. Campaigners disagree: they say a handover period built into the contract would have allowed a safe exit in 2027.
The Blindspot · what the headlines skip
Palantir's defenders skip the doubts about its numbers
The UK's statistics watchdog has warned NHS England there was no evidence for the claim that the platform helped deliver more than 100,000 extra operations. A network of NHS chief data officers said it had been “unable to demonstrate the level of evidence, confidence and realised value expected”.
The Blindspot · what the headlines skip
Palantir hasn't been ruled out of the next contract
Frith said UK firms would be encouraged to bid, but also “any international capability”. He said he would “note” McDonnell's call for a human rights test. The deal is also often called £330m, but one trade outlet puts its potential value at close to £500m.
Your Call
- MPs and campaigners: not yet
- What it means for you: not yet
- Palantir and its defenders: not yet
Only you can see this. It's saved on this device and never sent anywhere.
Receipts
Every source, one tap away
Don't take our word for it. This is everything the breakdown is built on.
By No Glaze News · published